Skip to content

Caffeine ingestion attenuates diurnal variation of lower-body ballistic performance in resistance-trained women.

PMID 35109780 (2023): caffeine — Time-trial performance, Time to exhaustion (study note for endurance athletes).

Last updated/Feb 23, 2026, 10:34 PM

Study note • PMID 35109780

Caffeine ingestion attenuates diurnal variation of lower-body ballistic performance in resistance-trained women.

European journal of sport science2023 • DOI 10.1080/17461391.2022.2038274
Evidence B70/100
Action 2: Consider

Worth trying if it fits your goal and context.

ELI5

In plain language

ABSTRACTThe present study investigates the effect of an acute intake of caffeine on the diurnal variation of neuromuscular performance in resistance-trained women. (randomized trial; trained participants).

The abstract doesn’t indicate a clear change in Time-trial performance under the tested conditions. Treat this as a signal, not a guarantee; confirm methods and context in the full paper.

Takeaways

What the abstract suggests

  • Study question: ABSTRACTThe present study investigates the effect of an acute intake of caffeine on the diurnal variation of neuromuscular performance in resistance-trained women.
  • The abstract doesn’t indicate a clear change in Time-trial performance under the tested conditions.
  • Population: trained participants.
  • Protocol cues (title/abstract): 3 mg/kg • 7 days.

Protocol

Protocol (as reported)

  • Intervention/exposure: caffeine (vs placebo).
  • Dose/time/duration cues in abstract/title: 3 mg/kg • 7 days.
  • Outcomes: Time-trial performance, Time to exhaustion.
  • Replication note: abstracts often omit adherence and timing; confirm details before changing training or supplementation.

Fit

Who it helps, and who should skip it

Who it helps

  • Athletes similar to the study population (trained participants) working on supplements.
  • Athletes who can measure Time-trial performance, Time to exhaustion with a repeatable workout or time-trial effort.

Who should skip

  • If you have symptoms or conditions that make the intervention risky, get professional guidance.
  • If you’re near race day and can’t safely test, defer the experiment.

Methods

What the study actually did

  • Design: randomized trial (placebo-controlled).
  • Population: trained participants.
  • Comparator: placebo.
  • Outcomes measured: Time-trial performance, Time to exhaustion.
  • Protocol cues mentioned: 3 mg/kg • 7 days.
  • Source: PubMed PMID 35109780 (2023) — European journal of sport science.

Results excerpt

What the abstract reports

No significant interaction (time-of-day x substance) was observed in any of the above-mentioned outcomes (all P > .1).

Note: excerpts are short; for full context, read the paper.

Limits

Limitations & bias

  • Abstract-only summaries can miss critical details (population, protocol, adherence, and context).
  • Single studies often don’t generalize to your event, history, and training load; treat results as a starting point.
  • If your context differs (elite vs recreational; cycling vs running), adjust expectations and be conservative.
  • This is performance information, not medical advice.

Coaching beta

Get a plan that adapts to your life.

Join the 26weeks.ai TestFlight beta for adaptive coaching, recovery-aware adjustments, and race-week reminders.

Keep going

Sources